MinorTrial status: Active, Not Recruiting to Completedv18
NotablePrimary completion date: Dec 2024 to Dec 2025
Study sites: 3 to 4
v17
NotablePrimary completion date: Dec 2023 to Dec 2024
Study completion date: Dec 2024 to Dec 2025
Eligibility criteria shortened, about 12 words
v16
Re-verified, no change to tracked fieldsv15
NotablePrimary completion date: Dec 2021 to Dec 2023
Study completion date: Dec 2022 to Dec 2024
v14
Show 12 earlier versionsHide 12 earlier versions
MinorPrimary completion date: Jul 2021 to Dec 2021
Study completion date: Dec 2021 to Dec 2022
v13
MinorTrial status: Enrolling by Invitation to Active, Not Recruiting
Study sites: 4 to 3
v12
NotablePrimary completion date: Jul 2020 to Jul 2021
Study completion date: Dec 2020 to Dec 2021
v11
Re-verified, no change to tracked fieldsv10
NotableLead sponsor: Vanderbilt University Medical Center to Vanderbilt Universityv9
NotableLead sponsor: Vanderbilt University to Vanderbilt University Medical Centerv8
NotablePrimary completion date: Dec 2014 to Jul 2020v7Show 4 more changesShow less
Enrollment target: estimated 400 to confirmed 432
Study completion date: Dec 2014 to Dec 2020
Study title revised
Study description expanded, about 2 words
MinorPrimary completion date: Dec 2014
Study completion date: Aug 2014 to Dec 2014
Eligibility criteria expanded, about 21 words
Study description expanded, about 7 words
v6
Re-verified, no change to tracked fieldsv5
MinorEnrollment target: 300 to 400v4Show 4 more changesShow less
Study sites: 3 to 4
Study completion date: Aug 2010 to Aug 2014
Collaborators: 1 to 2
Publications: 2 to 3
MinorTrial status: Recruiting to Enrolling by Invitation
Site details revised at 3 of 3 sites
v3
NotableTrial status: Not Yet Recruiting to Recruiting
Start date: Jul 2007 to Aug 2007
Site details revised at 3 of 3 sites
Eligibility criteria expanded, about 4 words
v2
Study First Submitted
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study we will examine patients who have undergone unilateral ACL reconstruction surgery to determine which structural and functional characteristics of the knee two and ten years post reconstruction surgery, aspects of the original injury and repair, and patient characteristics are risk factors for osteoarthritis after ACL reconstruction surgery.
Trial Details
NCT Number
NCT00478894
Lead Sponsor
Vanderbilt University Collaborators: National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions (from sponsor)
Rupture of Anterior Cruciate Ligament, Osteoarthritis